Expanded Access for IMMU-132
- Conditions
- Metastatic Triple-Negative Breast Carcinoma
- Registration Number
- NCT04320693
- Lead Sponsor
- Gilead Sciences
- Brief Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to IMMU-132.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- APPROVED_FOR_MARKETING
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Exclusion Criteria
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method